![Philippines grants asylum to Iranian beauty queen who feared death if deported | South China Morning Post Philippines grants asylum to Iranian beauty queen who feared death if deported | South China Morning Post](https://cdn.i-scmp.com/sites/default/files/styles/1200x800/public/d8/images/methode/2019/11/09/8d1177b8-0234-11ea-ab68-c2fa11fa07a6_image_hires_073452.jpg?itok=3X1QiE0J&v=1573256099)
Philippines grants asylum to Iranian beauty queen who feared death if deported | South China Morning Post
WrestleOslo: Taylor, Yazdani set up gold-medal showdown; USA puts 3 in finals | United World Wrestling
![University of Tennessee at Chattanooga commencement program, 2016 December 17 - University of Tennessee at Chattanooga Commencement programs - University of Tennessee at Chattanooga Digital Collections University of Tennessee at Chattanooga commencement program, 2016 December 17 - University of Tennessee at Chattanooga Commencement programs - University of Tennessee at Chattanooga Digital Collections](https://digital-collections.library.utc.edu/digital/api/singleitem/image/p16877coll24/3372/default.jpg)
University of Tennessee at Chattanooga commencement program, 2016 December 17 - University of Tennessee at Chattanooga Commencement programs - University of Tennessee at Chattanooga Digital Collections
![Hossein ZARE | Programmer/Research Data Analyst/Faculty (Adj) | MS, PhD | Health Policy and Management, International Health Hossein ZARE | Programmer/Research Data Analyst/Faculty (Adj) | MS, PhD | Health Policy and Management, International Health](https://i1.rgstatic.net/ii/profile.image/606341697634304-1521574534101_Q512/Hossein-Zare-8.jpg)
Hossein ZARE | Programmer/Research Data Analyst/Faculty (Adj) | MS, PhD | Health Policy and Management, International Health
![A Phase 3 Placebo-Controlled Trial of Once-Daily 400-mg and 600-mg SPN-812 (Viloxazine Extended- Release) in Adolescents with ADHD (OPEN ACCESS) - MedWorks Media A Phase 3 Placebo-Controlled Trial of Once-Daily 400-mg and 600-mg SPN-812 (Viloxazine Extended- Release) in Adolescents with ADHD (OPEN ACCESS) - MedWorks Media](https://medworksmedia.com/wp-content/uploads/2021/04/043-064_PB-51-2-2021-Nasser.jpg)